Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Dec 06, 2022 3:26pm
109 Views
Post# 35154271

RE:Huge volume on the "bid" - none on the "ask"

RE:Huge volume on the "bid" - none on the "ask"How much lower can it get Mr "Easy Double"

$0.065 a share.

The bashing and trolling if we are to belive are the only things that caused this to tank has been a huge success without even a wimper from the ceo that is the true cause of this failure.

Maybe when it gets down to $0.01 your "easy double" prediction you have been saying for the past year will actualy happen.

I dont know how you can still text on this board after the BS you have put down here.

gojotv! wrote: All that bashing and trolling are having little effect.
Shareholders just need to read the news releases to know what we've got!
And them's that's got, ain't lettin' go!  lololol
GLTA far-sighted, basher-ridiculing investors!




<< Previous
Bullboard Posts
Next >>